05.10.2022 | pharmaceutical forum
Published in: MMW – advances in medicine | Special issue 5/2022
abstract
According to Tilray, therapy with medical cannabis is highly individual and requires approaching the right composition and dosage. To start treatment, it has often been recommended that cannabis-naïve people should receive a product with a balanced tetrahydrocannabinol-cannabidiol (THC-CBD) ratio (e.g. Tilray ® THC10:CBD10). In the further course of treatment, the THC or CBD content should be increased depending on the symptoms.